<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-8-57</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-8-8-1</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurofibromatosis</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Optic Pathway Tumors and NF-1</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>08</month>
<year>1994</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>06</month>
<year>2016</year>
</pub-date>
<volume>8</volume>
<issue>8</issue>
<fpage>57</fpage>
<lpage>57</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1994 The Author(s)</copyright-statement>
<copyright-year>1994</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1016/S0022-3476(94)70122-9" vol="125" page="63">
<article-title>Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal study</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>The natural history of 33 optic pathway tumors (OPT) diagnosed in 227 children with neurofibromatosis type 1 (NF-1) seen in a specialty clinic was evaluated in a prospective, longitudinal study at Children&#x2019;s Memorial Hospital and Northwestern University Medical School, Chicago.</p>
</abstract>
<kwd-group>
<kwd>Optic Pathway Tumors</kwd>
<kwd>Neurofibromatosis Type 1</kwd>
<kwd>Chiasmatic Tumors</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The natural history of 33 optic pathway tumors (OPT) diagnosed in 227 children with neurofibromatosis type 1 (NF-1) seen in a specialty clinic was evaluated in a prospective, longitudinal study at Children&#x2019;s Memorial Hospital and Northwestern University Medical School, Chicago. OPTs were found in 19% of 176 who had CT or MRI at a median age of 4.2 years. No OPT developed on later follow-up in children who had not received an MRI. In those without ophthalmological complaints at diagnosis, the incidence of OPT was 15%. The median age of children with ophthalmologic complaints such as proptosis or glaucoma (1.9 years) was significantly lower than that of children without such complaints (5.3 years). Only 8 tumors were discovered because of visual complaints or precocious puberty; 25 (76%) children were asymptomatic at time of diagnosis, and 21 (64%) had normal eye findings. Six with chiasmal tumors had decreased visual acuity without proptosis. At follow-up of 0.2 - 8 years, only 3 (9%) showed progressive tumor growth on MRI or deteriorating vision after diagnosis. Symptomatic OPT were diagnosed before the age of 6 years. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<disp-quote>
<p>COMMENT. The child with NF-1 is at greatest risk for symptomatic optic pathway tumor during the first 6 years of life. Tumor growth after 6 years is unusual. Progressive abnormalities and precocious puberty occurred only with chiasmatic tumors. Tumors confined to the optic nerve discovered by screening with MRI were not accompanied by decreased visual acuity or evidence of progression. The authors advocate serial ophthalmologic examinations in young children with neurofibromatosis type 1, but find that serial MRI is of limited value in asymptomatic patients. The frequency and indications for neurological and neurosurgical consultations in these patients would be of interest.</p>
</disp-quote>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Listernick</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Charrow</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Greenwald</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mets</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal study</article-title>
<source>J Pediatr</source>
<year>1994</year>
<month>Jul</month>
<volume>125</volume>
<issue>1</issue>
<fpage>63</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-3476(94)70122-9</pub-id>
<pub-id pub-id-type="pmid">8021787</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>